Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Ovarian Cancer × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 87 Breast Neoplasms 68 Prostatic Neoplasms 33 Triple Negative Breast Neoplasms 32 Fallopian Tube Neoplasms 25 Neoplasms 23 Neoplasm Metastasis 21 Pancreatic Neoplasms 19 Endometrial Neoplasms 18 Small Cell Lung Carcinoma 13 Carcinoma, Ovarian Epithelial 11 Carcinoma, Non-Small-Cell Lung 10 Stomach Neoplasms 9 Sarcoma 9 Recurrence 9 Lung Neoplasms 9 Fanconi Anemia, Complementation Group D1 9 Squamous Cell Carcinoma of Head and Neck 8 Glioma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Glioblastoma 7 Colorectal Neoplasms 6 Metastatic Castration-resistant Prostate Cancer 5 Lymphoma, Non-Hodgkin 5 Cholangiocarcinoma 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Solid Tumors 4 Osteosarcoma 4

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Neoadjuvant Therapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡